Feasibility of Process-based Therapy in a Naturalistic Setting
PBaPP
1 other identifier
interventional
40
1 country
1
Brief Summary
The main objective is to explore the feasibility of Process-based Therapy in a natural mental health care setting delivered by practitioners.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 4, 2023
CompletedFirst Submitted
Initial submission to the registry
July 27, 2024
CompletedFirst Posted
Study publicly available on registry
July 31, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedMarch 19, 2026
March 1, 2026
2.4 years
July 27, 2024
March 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Client Satisfaction Questionnaire (CSQ)
Treatment satisfaction , minimum value= 8, maximum value= 32, higher scores mean better outcome
From the time of randomization until the end of treatment, assessed no later than 28 weeks
Patient attitude towards utility of EMA and networks Scale (PAUEN)
Attitude towards utility of EMA and network models, minimum value= 8, maximum value= 40, higher scores mean better outcome
From the time of randomization until the end of treatment, assessed no later than 28 weeks
Therapist attitude towards utility of EMA and networks Scale (TAUEN)
Attitude towards utility of EMA and network models, minimum value= 6, maximum value= 30, higher scores mean better outcome
From the time of randomization until the end of treatment, assessed no later than 28 weeks
Treatment Evaluation Inventory (TEI)
Acceptance of treatment, minimum value= 7, maximum value= 98, higher scores mean better outcome
From the time of randomization until the end of treatment, assessed no later than 28 weeks
Attrition rate
The percentage of participants who withdraw before completing the final assessment
From the time of randomization until the end of treatment, assessed no later than 28 weeks
Secondary Outcomes (9)
Euroqol-5D (EQ-5D)
Assessed after randomization and assessed until the end of treatment, assessed no later than 28 weeks at post-treatment
Positive-Mental Health Scale (PMH)
Assessed after randomization and assessed until the end of treatment, assessed no later than 28 weeks at post-treatment
Depression Anxiety Stress Scale (DASS-10)
Assessed after randomization, after completion of the EMA baseline phase (intermediate) and assessed until the end of treatment, assessed no later than 28 weeks at post-treatment (week 28)
Acceptance and Action Questionnaire Version 2 (AAQ-2)
Assessed after randomization, after completion of the EMA baseline phase (intermediate) and assessed until the end of treatment, assessed no later than 28 weeks at post-treatment
Reflective Functioning Questionnaire (RFQ-8)
Assessed after randomization, after completion of the EMA baseline phase (intermediate) and assessed until the end of treatment, assessed no later than 28 weeks at post-treatment
- +4 more secondary outcomes
Study Arms (2)
Process-based Cognitive Behavioral Therapy
EXPERIMENTALIn PBT, treatment planning is based on a dynamic network analysis of EMA data collected during the baseline phase. Therapists identify the central node, significant edges, self-loops, and feedback loops between the nodes. Using this information, interventions are selected based on empirical evidence for mechanisms of change that correspond to the network characteristics. These interventions are framed within an evolutionary framework as the variation, selection, and retention of an adaptive mode of the central node in relation to the specific context of the problem. The change in this key variable is monitored through daily judgments based on EMA. Treatment also focuses on additional targets to establish adaptive modes of the dimensions as defined in the positive network model. Concomitant medication is allowed and will be controlled in statistical analyses.
Routine practice (r-PT)
ACTIVE COMPARATORIn r-PT, as opposed to PBT, a naturalistic setting is retained for treatment decisions. Treatment planning follows traditional theories about the factors maintaining the disorder and interventions changing them, e.g. avoidance and exposure in anxiety disorders or reduced reinforcement of activities and behavioral activation in depression. Interventions are based on common treatment manuals related to diagnoses, e.g. CBT for depression. Individual data from the behavioral analysis are used to tailor the techniques to the individual problems of the patients. Treatment process is largely structured by personal preferences of the therapist due to experience, knowledge or recommendations of the National guidelines for the mental health problem.Concomitant medication is allowed and will be controlled in statistical analyses.
Interventions
Intervention planning based on the use of EMA data, feedback of dynamic network analysis and matching of interventions to central nodes of the network.
Eligibility Criteria
You may qualify if:
- A primary DSM-5 diagnosis of a depressive or anxiety disorder
- Age 18-65 years
- Sufficient knowledge of the German language
- Participating patients are not required to discontinue medication, but to keep medication constant over the treatment period
You may not qualify if:
- Increased suicidality
- Substance abuse or dependency
- Diagnose of a cluster A or B (DSM-5) personality disorder
- Pervasive developmental disorder
- Psychotic disorder
- Eating disorder
- Bipolar disorder
- Severe physical illness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Goethe Universitylead
- Philipps University Marburgcollaborator
Study Sites (1)
JWGUniversity
Frankfurt am Main, Hesse, 60486, Germany
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of the Department of Clinical Psychology and Psychotherapy and Center for Psychotherapy
Study Record Dates
First Submitted
July 27, 2024
First Posted
July 31, 2024
Study Start
November 4, 2023
Primary Completion
April 1, 2026
Study Completion
April 1, 2026
Last Updated
March 19, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
- Time Frame
- Beginning 3 months and ending 5 years following article publication. Data are available for 5 years at a third-party website (Link to be included).
- Access Criteria
- Proposals should be directed to stangier@psych.uni-frankfurt.de. To gain access, data requestors will need to sign a data access agreement.
Individual participant data that underlie the results reported in the main publication of outcomes, after deidentification (text, tables, figures, and appendices) will be shared. Further Study Protocol, Analysis Plan, Informed Consent Form and Analytic Code will be shared to researchers who provide a methodologically sound proposal.